Design and competitive considerations in the research development, and launch of pharmaceutical products in the Lebanese market. (c2010)

2010 ◽  
Author(s):  
Rudy Keyrouz
Keyword(s):  
Pharmaceutical Products ◽  
Research Development

Vioxx and other pharmaceutical product withdrawals: ethical issues in ensuring the integrity of drug and medical device research, development and commercialization

2007 ◽  
Vol 2 (3) ◽  
pp. 155-162 ◽  
Author(s):  
K L Phua ◽  
F I Achike
Keyword(s):  
Medical Device ◽  
Ethical Issues ◽  
Pharmaceutical Products ◽  
Pharmaceutical Product ◽  
Research Development ◽  
End User ◽  
Post Marketing Surveillance ◽  
Post Marketing ◽  
Ordinary Person ◽  
Device Research

The Vioxx drug recall and other cases of withdrawals of approved pharmaceutical products as a result of reports of serious harm to users indicate that there are many problems associated with the process of getting these products to the end user the ordinary person in the street. The problems include those related to drug/medical device research and development, clinical trials, presentation and publication of research results, approval by regulatory authorities, preparation of clinical practice guidelines, marketing of products by commercial companies and post-marketing surveillance. This article discusses threats to the integrity of each of these processes and argues that the steady stream of drug recalls indicates the existence of a systemic problem. It concludes with a discussion of possible solutions to these problems.

Introduction to the new WPPSIIV - Australian & New Zealand Edition: Research, Development and Interpretation

2014 ◽  
Author(s):  
Elise Harrison ◽  
Valorie O'Keefe ◽  
Susan Engi Raiford ◽  
Diane L. Coalson
Keyword(s):  
New Zealand ◽  
Research Development

Research & Development of New Occupational Analysis & Training Evaluation Technologies

1997 ◽  
Author(s):  
Jimmy L. Mitchell ◽  
David Tucker ◽  
Jonathan Fast ◽  
Winston Bennett ◽  
Walter G. Albert
Keyword(s):  
Training Evaluation ◽  
Research Development

Problems Facing the Arab Pharmaceutical Industry: A Case Study from Yemen

2016 ◽  
Vol 2 (4) ◽  
pp. 234-241
Author(s):  
Mohammed Al-Shakka ◽  
Ebtesam Abood ◽  
Adel Al-Dhubhany ◽  
Sami Abdo Radman Aldubai ◽  
Khaled Said ◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Low Income ◽  
Well Being ◽  
Pharmaceutical Products ◽  
Domestic Market ◽  
Raw Material ◽  
Political Crisis ◽  
Pharmaceutical Manufacturer ◽  
University Graduates ◽  
Pharmaceutical Drugs

Because of the almost-instant connection with the welfare and well-being of individuals, pharmaceutical industry stands prominently as a very important factor for the improvement and progress of a healthy productive nation. These days, pharmaceutical industry thrives as one of the largest and exponentially expanding global industries. Nonetheless, millions of people in low income developing countries, have to suffer from the fatal consequences of the inaccessibility and non-availability of essential drugs. This is also happening in Yemen, where the pharmaceutical manufacturers sector have to face up to many challenges. The Yemen Drug Company (YEDCO) was founded in 1964 by the Yemeni government as it collaborated with private investors. It was endorsed as a company with the expertise in the medicinal drug marketing. YEDCO started its work by taking in drugs from foreign companies and then locally marketing and distributing them. In 1982, YEDCO built the first medicinal factory for drugs in Sana’a. Since then, seven companies were set up to manufacture medicines in Yemen. The expanding population has led to the need to have more pharmaceutical products. It may be understandable that pharmaceutical manufacturer companies are also hit by the political crisis in the country. Inadequate amount of fuel and raw material as well as low security status were some of the underlying factors behind these ill-effects in Yemen. Imported drugs make up about nearly 90% % of the pharmaceutical market compared to 10% drugs from the domestic market. This situation has led to an additional burden being shouldered by the national economy, where Yemen spends about US$263 million annually on pharmaceutical drugs, in reference to the national Supreme Drugs Authority. Although there is a very quick growth in the population and drugs consumption, the pharmaceutical industry has not been very active, where global pharmaceutical products play their role dominantly on the domestic market. The pharmaceutical production necessitates skilled human resources like university graduates. By contrast, the government and the private sector should also motivate the pharmaceutical industry and make use of the local employment

Sign in / Sign up

Export Citation Format

Share Document